Scientific Library
- Acute Coronary Syndrom
- ASCVD Prevention
- Bifurcation Stenting
- Cardio-Oncology
- Congestive Heart Failure
- DAPT Duration
- Drug Coated Balloon
- Fractional Flow Reserve
- IVUS Guidance
- Optical Coherence Tomography
- Pulmonary Hypertension
- Rotational Atherectomy
- Shear Stress
- Stenting Left Main
- Transcatheter Aortic Valve Replacement
- Percutaneous LAA Occlusion
- Mitral/Tricuspid Valvular Disease
- Other Relevant Articles
-
Revascularization Strategies in STEMI with Multivessel Disease: Deciding on Culprit Versus Complete-Ad Hoc or StagedPatel S, Bailey SR. -
Complete Revascularization During Primary Percutaneous Coronary Intervention Reduces Death and Myocardial Infarction in Patients With Multivessel Disease-Meta-Analysis and Meta-Regression of Randomized TrialsV Pasceri, G Patti, F Pelliccia et al.
-
Characterization of lesions undergoing ischemia-driven revascularization after complete revascularization versus culprit lesion only in patients with STEMI and multivessel disease - A DANAMI-3-PRIMULTI substudyDe Backer O, Lønborg J, Helqvist S et al.
-
MR-proADM as a Prognostic Marker in Patients With ST-Segment-Elevation Myocardial Infarction-DANAMI-3 (a Danish Study of Optimal Acute Treatment of Patients With STEMI) SubstudyFalkentoft AC, Rørth R, Iversen K et al.
-
Natural History of Spontaneous Coronary Artery Dissection With Spontaneous Angiographic HealingHassan S, Prakash R, Saw J et al.
-
Pharmacoinvasive and Primary Percutaneous Coronary Intervention Strategies in ST-Elevation Myocardial Infarction (from the Mayo Clinic STEMI Network)Siontis KC, Barsness GW, Gersh BJ et al.
-
Complete Revascularization with Multivessel PCI for Myocardial InfarctionMehta SR, Wood DA, COMPLETE Trial Steering Committee and Investigators.
-
Symptom onset-to-balloon time and mortality in the first seven years after STEMI treated with primary percutaneous coronary interventionRollando D, Puggioni E, Robotti S et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
